Related Experiment Video
Updated: Apr 23, 2026

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Pharmacologic treatments for esophageal disorders
L Ashley Blackshaw1, Dmitry S Bordin, Christina Brock
1Centre for Digestive Diseases, Blizard Institute of Cell & Molecular Science, Wingate Institute of Neurogastroenterology, Barts and the London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom.
This conference explored novel treatments for esophageal disorders, including alternative therapies like ketamine and linaclotide for pain. It also covered diagnostic tools for GERD and drug delivery methods for esophageal conditions.
Area of Science:
- Gastroenterology and Esophageal Disorders
- Pharmacology and Therapeutics
- Diagnostic Medicine
Background:
- The 12th OESO World Conference convened experts to discuss advancements in esophageal disorder management.
- Key areas of focus included alternative treatments, diagnostic criteria, and drug efficacy for esophageal conditions.
Framework:
- The conference featured commentaries on emerging therapeutic strategies and diagnostic approaches.
- Discussions encompassed pharmacological interventions, including receptor antagonists and local drug formulations.
- Novel diagnostic methods like the alginate test for gastroesophageal reflux disease (GERD) were presented.
Implementation:
- Exploration of ketamine and alternative treatments for various esophageal disorders.
- Evaluation of linaclotide for managing esophageal pain.
- Assessment of the alginate test for diagnosing GERD.
- Review of baclofen and receptor antagonists in GERD treatment.
- Analysis of opioid effects on the esophagus.
- Consideration of local drug formulations for esophageal mucosa.
- Utilizing electroencephalographic (EEG) fingerprints to predict treatment response.
Implications:
- Potential for improved patient outcomes through diverse therapeutic options.
- Advancements in diagnostic accuracy for conditions like GERD.
- Enhanced understanding of drug interactions and delivery mechanisms in esophageal treatment.
- Future directions in personalized medicine for esophageal diseases based on predictive biomarkers.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Barrett Esophagus-II: Clinical Manifestations and Management
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
Esophageal Achalasia
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...

